Five additional companies were given the greenlight Tuesday by the state’s Department of Health to manufacture and dispense medical marijuana in New York state, despite a trade group’s lawsuit opposing additional growers.
The five organizations—Citiva Medical, Fiorello Pharmaceuticals, New York Canna, PalliaTech NY and Valley Agriceuticals—join the five other medical marijuana groups that were granted a license in January 2016 to grow and sell medical marijuana to residents of the state with severe illnesses, such as cancer, HIV, AIDS, ALS or Parkinson’s disease.
